On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
New technologies and care plans aim to enhance treatment options for patients in Mitchell and the surrounding area ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as ...
The 32nd international conference of the Indian Association of Palliative Care (IAPC) commenced at the All India Institute of Medical Sciences (AIIMS) here on Friday, officials said. Jammu and Kashmir ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...